By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


iBio, Inc. 

9 Innovation Way
Suite 100
Newark  Delaware  19711  U.S.A.
Phone: 302-355-0650 Fax: 302-356-1173


Company News
iBio, Inc. (IBIO) Receives FDA Orphan Drug Designation For Fibrosis Product Candidate 7/5/2016 12:35:25 PM
iBio, Inc. (IBIO) Receives New Patent For Its Biotherapeutic Products For Treatment Of Fibrosis 6/30/2016 12:16:12 PM
Texas A&M University System And iBio, Inc. (IBIO) Execute Joint Development Agreement For Plant-Produced Pharmaceuticals 6/7/2016 9:17:27 AM
iBio, Inc. (IBIO) Holds Annual Meeting In College Station, Texas 4/11/2016 12:42:19 PM
iBio, Inc. (IBIO) Unveils First Of Its Kind Patient Center Empowering Patients To Positively Impact The Future Of Research 2/12/2016 9:02:47 AM
iBio, Inc. (IBIO) Forms Joint Venture CMO For Large-Scale Pharmaceuticals Manufacturing In Green Plants And Accepts Additional Investment 1/14/2016 10:03:19 AM
iBio, Inc. (IBIO) Continues Global Expansion Of Intellectual Property 12/1/2015 11:45:00 AM
iBio, Inc. (IBIO) Release: Scientific Insights Into IBIO-CFB03 Presented At American College of Rheumatology Annual Meeting 11/20/2015 12:45:14 PM
iBio, Inc. (IBIO) European Protein Expression Patent Emerges From Opposition Period 10/27/2015 9:43:05 AM
New Chinese iBioModulator Patent Joins iBio, Inc. (IBIO) Vaccine Portfolio 9/30/2015 12:27:41 PM